og体育
join us
CN
Home page
About Us
Profile
og体育:Affiliates/Subsidiaries
Development History
og体育:Quality Management
Contact Us
og体育:Legal Statement
Adverse Reaction Report
og体育:Science and Technology
og体育:R&D platform
og体育:R&D pipeline
og体育:Therapeutic Field
International Business
APIs
og体育:Finished Products
og体育:Medical device
Download product list
Contact
News Center
og体育:News & Trends
og体育:Public information
News & Trends
182023-01
Progress of S086 for the treatment of mil🐟d to moderate primary hypertension
112023-01
Clinical trial approved! Good news for SA🍸L0133 tablets
112023-01
SAL008 injection for the treatmen🔯t of advanced solid tumors approved for clinical triꦯal
112023-01
The application for a clinical trial of SAL0133 tablets for the treatment of mild/coജmmon COVID-19 in adults was accepted
112023-01
New clinical progress of SAL003 for the treatment of hyperchꦅolesterolem🐽ia and mixed hyperlipidemia
112023-01
Two a⛄lliances for Biomedicine and high-end medical devices established
目前在第
2
页,
共有
9
页,
共有
50
条记录
第一页
上一页
1
2
3
4
5
下一页
最后一页
跳转到
页
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7fDzSfyJvbjbD",ck:"K9y7fDzSfyJvbjbD"});
谈球吧体育(中国) - 官网app下载
OG体育(中国) - 官方网站
OG体育·(中国)平台
og体育(中国)- app下载